**Pharmacology and Novel Therapeutic Techniques for Treatment of Systolic Heart Failure**

complex patients. It also serves as a stepping stone to what I truly believe will be a growing

Section 1 explores newer pharmacology and novel therapeutic techniques in the treatment of systolic heart failure. Section 2 focuses on the role of implantable devices in the manage‐ ment of systolic heart failure including the impact of cardiac resynchronization therapy (CRT), addressing who is most likely to respond and how we can optimize this response. Section 3 discusses the role of transcatheter ablative therapy in the management of atrial fibrillation and other arrhythmias in patients with heart failure. The final section looks at the

I want to extend a heartfelt thank you to the collection of international authors who contrib‐ uted to this textbook, without whom this textbook would not have been possible. It is my hope that the textbook will meet its stated objective and will serve as the fodder for physi‐ cians at all levels of training to appreciate the intimate role of the these two important disci‐

I would like to extend a thank you to Carolyn my partner in crime who had to endure end‐ less hours without me while I was preparing this book. I also want to thank my twin daugh‐ ters Alexis and Denae who are busy with Medical and Law schools, respectively, and had to endure my lateness to many social engagements. Without everyone's patience, this book

Director of Clinical Cardiac Electrophysiology Section and Fellowship Program

**Dr. John Kassotis**

New York, USA

SUNY Downstate Medical Center

body of literature.

VIII Preface

The textbook is organized in four sections:

plines of cardiovascular medicine.

would not have been possible.

impact of thyroid disease in congestive heart failure.
